Forsea Foods, Ltd., a FoodTech start-up, is the first company to use organoid technology for culturing seafood products. With a goal of redressing the destruction of marine life due to overfishing, Forsea embarked on a mission to cultivate seafood—initially eel meat—without harming sea life. The eel has become an endangered species, while the demand for its meat keeps increasing in markets such as Europe and Asia.
Toward this effort, Forsea has raised USD5.2M in a seed round led by Berlin-based Target Global. Also invested in the round were The Kitchen FoodTech Hub; PeakBridge VC; Zora Ventures; FoodHack, and Milk & Honey Ventures. The new funding will initially go towards growing cultivated eel meat, high in demand for kabayaki and sushi. Target Global’s contribution to this round marks one of its first investments in the foodTech industry.
Founded a year ago with the support of The Kitchen FoodTech Hub part of The Strauss-Group, Forsea is dedicated to preserving the fish population by creating a viable alternative to wild-caught seafood and leaving the fragile marine ecosystem completely untouched.
Organoid platform vs scaffolding cultivated seafood
Forsea utilizes a non-GMO organoid platform in which the eel meat is grown ex vivo as a three-dimensional tissue structure in the same manner it would grow in a living fish.
This technology bypasses the scaffolding stage and requires fewer bioreactors, a process that is much simpler and more cost-effective than traditional cell culturing. It also dramatically reduces the amount of expensive growth factors required, making the final product more affordable. Iftach Nachman, PhD, co-founder of Forsea, developed the organoid technology to solve the bottleneck of the eel meat industry.
“We are eager to take part in Forsea’s quest to create sustainable, better-for-you seafood products that do not disrupt the biodiversity of the oceans,” says Shmuel Chafets, Executive Chairman and founder of Target Global. “Forsea is poised to make a dramatic impact on the seafood ecosystem. Its pillar platform solves a bottleneck in the cultivated meat industry by creating affordable, ethical, cultivated seafood products that can replace vulnerable fish species.”
Forsea will inaugurate its pilot plant during 2023. The plant will allow the company to create a preliminary design for a large-scale alpha production system, and to launch the company’s first products. The start-up will invest the newly raised capital to accelerate R&D for both growing eel meat and developing the process for other fish species. Forsea also will improve and expand its core technology to enable organoid growth in large-scale bioreactors, while developing methods to increase production yield and profitability at a lower cost. These include perfecting a continuous feeding strategy and nutritional support. Recently Forsea expanded its R&D team and activities to Rehovot, in the heart of Israel’s FoodTech valley.
“We are very excited to announce the completion of this funding round,” states Roee Nir, CEO, a biotechnology engineer and co-founder of Forsea. “Our investors express their trust in our game-changing technology for producing seafood with a minimal footprint on the environment. The patented organoid technology allows us to contribute to a safe and more resilient food system consumers demand.”
“We are extremely pleased to invest in Forsea and welcome the company into our growing portfolio,” comments Yoni Glickman, Managing Partner of FoodSparks by PeakBridge. “Forsea has demonstrated breakthrough technology, having recruited an experienced team to solve a significant problem in the food system caused by overfishing and habitat loss.”
“Depletion of world fisheries is a major threat to our food security,” adds Amir Zaidman, Chief Business Officer of The Kitchen Hub. “For this reason we teamed up with Nir and the founding team and backed Forsea from its inception at The Kitchen. We are proud to continue our support and to participate in the seed round of Forsea as it continues to attain its goals.”
“We can produce a product identical in flavor, texture, appearance, and nutritional values to real eel,” emphasizes Nir. “Organoid platform allows us to design the fish fillet exactly as it grows in the fish, that is, in a 3-dimensional structure, without growing the fat and muscle tissues separately.”
The three co-founders—biotech engineer Roee Nir, MBA; Iftach Nachman, PhD; and Yaniv Elkouby, PhD—founded Forsea in October, 2021 with support from the Israeli Innovation Authority (IIA) and The Kitchen Hub. Nir, A biotech engineer with an MBA from NYU Stern, has held years of executive roles in Foodtech, Biotech and Digital Health companies. Nachman, a senior researcher at Tel Aviv University, developed the technology through several grants received from The Good Food Institute. Elkouby, a senior researcher at the Hebrew University of Jerusalem and expert in cell developmental biology, devoted decades to studying piscine biology.
The organoid approach to cultivating fish tissue involves creating an ideal environment for fish cells to spontaneously form their natural composition of native fat and muscle. They grow as a three-dimensional tissue structure, just like, they would grow in a nature
About Target Global
Target Global is a pan-European technology investment firm with more than €3 billion in assets under management. It invests in companies across all stages of their lifecycle, from pre-seed to pre-IPO. Since 2012, Target has invested in global winners including Delivery Hero, Revolut, Auto 1 Group, Copper, Rapyd, Wefox, Flink, Cazoo, and many others. Target’s experienced team of investors, many of whom began their journeys as founders and operators, help exceptional entrepreneurs build leading companies that target trillion-dollar markets. To date, Target has backed 15 unicorns, had 21 exits and 7 realized IPOs. Target has six offices around the world with investing offices across Berlin, London, Tel Aviv, and Barcelona. To learn more about Target Global, please visit: https://www.targetglobal.vc